In the press

Press releases & News

Lavie Bio Announces Commercial Launch of its First Microbiome-Based Product for Yield Improvement – result™

result™ inoculant initially introduced for spring wheat in North Dakota, following positive four-year field trials Rehovot, Israel – November 3, 2021 — Lavie Bio Ltd., a subsidiary of Evogene Ltd. (NASDAQ: EVGN, TASE: EVGN), and a leading ag-biologicals company focusing on improving food quality and agricultural productivity and sustainability through the introduction of microbiome-based products,

Read more

Lavie Bio and United Agronomy Announce Signing of Distribution Agreement for Lavie Bio’s Inoculant Product

Commercialization targeted for 2022 for spring wheat initially   Rehovot, Israel and Berthold, ND, USA – September 29, 2021 — Lavie Bio Ltd. (Lavie), a subsidiary of Evogene Ltd. (NASDAQ: EVGN, TASE: EVGN), and a leading ag-biologicals company focusing on improving food quality, sustainability, and agriculture productivity through the introduction of microbiome-based products, and United

Read more

Lavie Bio Announces the Appointment of Russ Putland as Vice President Commercial

This appointment continues Lavie Bio’s advancement of its commercial pipeline, focusing on its planned product launches starting 2022   Rehovot, Israel – May 25th, 2021 – Lavie Bio Ltd., a leading ag-biologicals company focusing on improving food quality, sustainability, and agriculture productivity through the introduction of microbiome-based products, and a subsidiary of Evogene Ltd. (NASDAQ:

Read more

Lavie Bio Provides Product Pipeline Update for 2020

LAV211 bio-stimulant advancing towards anticipated 2022 commercial launch in spring wheat; Product advancement achieved in multiple programs   Rehovot, Israel – December 29, 2020 – Lavie Bio Ltd. (Lavie Bio), a leading ag-biologicals company focusing on improving food quality, sustainability and agriculture productivity through the introduction of microbiome-based products, and a subsidiary of Evogene Ltd.

Read more